×
Hero Background

Asia Pacific CRO Companies

ID: MRFR/HC/11119-HCR
128 Pages
Rahul Gotadki
October 2025

Asia Pacific Cro (Contract Research Organization) companies play a pivotal role in the region's pharmaceutical and biotechnology sectors. These dynamic organizations specialize in providing outsourced research and development services, spanning preclinical and clinical trials to regulatory submission support.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Asia Pacific CRO Market Research Report—Global Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Asia Pacific CRO Market

Asia CRO Key Companies

Latest Asia CRO Companies Update



Surging clinical trial activity APAC now accounts for over 50% of global clinical trials, attracting sponsors with its diverse patient populations, favorable regulatory environments, and cost-effective solutions.


WuXi AppTec Acquired US-based Altimmune for $1.7 billion, strengthening its global reach and capabilities in biologics development and manufacturing.


Syneos Health Expanded its APAC footprint by acquiring Australia-based Clinical Research Consulting Services (CRC Services) and Indian CRO Clinigene.


Parexel Partnered with Chinese biotech company CTTQ to establish a joint venture focused on clinical trial execution in China.


List of Asia CRO Key companies in the market

  • IQVIA Inc.

  • Parexel International Corporation

  • Charles River Laboratories, Inc.

  • ACM Global Laboratories

  • Merck KGaA (Bio Reliance Corporation)

  • Celerion

  • Clinitude

  • Laboratory Corporation of America Holdings (Covance Inc.)

  • Novotech

  • Icon PLC